Base Anatomo Clinique de l Adénocarcinome Pancréatique

Similar documents
DAYS IN PANCREATIC CANCER

Development of a Retrospective and Prospective Multidisciplinary Pancreas Database

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

ANRS CO12 CIRVIR - Prospective cohort involving patients with viral cirrhosis B and C

Importance of Methodology Certification and Accreditations to Perform Assays. Stan Hamilton, MD Head, Pathology and Laboratory Medicine

Lara Kujtan, MD; Abdulraheem Qasem, MD

LCA Lung Clinical Forum. 21 st October 2014

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

PRAC non-interventional imposed PASS final study report assessment report

PCaP Snapshot. Baseline Data Collection

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Author s response to reviews

Optimal Treatment Strategies for Localized Ewing s Sarcoma of Bone after Neoadjuvant Chemotherapy

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:

Surveillance of Pancreatic Cancer Patients Following Surgical Resection

Promoting Innovative Practice

Analysis of factors influencing molecular testing at diagnostic of colorectal cancer

Positioning. > MEMENTO is a large observational study enrolling patients at an. Data first availability for project analyses

Lung Cancer: Diagnosis, Staging and Treatment

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)

10 years Congenital survey in France

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Primary Endpoint The primary endpoint is overall survival, measured as the time in weeks from randomization to date of death due to any cause.

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors

Esophageal Cancer. Source: National Cancer Institute

Technical Guidance Note for Round 11 Global Fund HIV Proposals

3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis

Fundamental & Clinical Pharmacology

Pancreatic Cancer Registry Registry supervisor: Dr. Gábor Lakatos HPSG Chair: Prof. Dr. Péter Hegyi

Esophageal cancer. What is esophageal cancer? Esophageal cancer is a disease in which malignant (cancer) cells form in the tissues of the esophagus.

Management of Neck Metastasis from Unknown Primary

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018

Certificate of Advanced Studies in Personalized Molecular Oncology

Management of advanced non small cell lung cancer

AllinaHealthSystems 1

BREAST PROGRAM A TEAM APPROACH TO CARE

Général. Identification

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database

National Breast Cancer Audit next steps. Martin Lee

Implementation of nation-wide molecular testing in oncology in the French Health care system : quality assurance issues & challenges

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of

The orthopedic-oncology service : a multidisciplinary team

COMMUNITY CANCER PROGRAM ACCREDITATION WITH COMMENDATION BY THE COMMISION ON CANCER

Potential Opportunities for Collaboration with Pancreatic U01s

DEPARTMENT OF ONCOLOGY ELECTIVE

Imaging in gastric cancer

Online Supplement. Relationship Between OSA Clinical Phenotypes and CPAP Treatment Outcomes

Maria João Cardoso, MD, PhD

Team Progress Updates. SU2C Pancreatic Dream Team: Cutting Off the Fuel Supply: A New Approach in the Treatment of Pancreatic Cancer

Histological Typing Of Cancer And Precancer Of The Oral Mucosa

Targeting and Treating Cancer

Surgical Management of Pancreatic Cancer

Different Types of Cancer

Corporate Medical Policy

Single Technology Appraisal (STA)

Experiences from building up the Danish National Clinical Cancer Database

Pancreatic Adenocarcinoma: What`s hot

Perspective économique sur les traitements ciblés Valérie Seror

Pancreatic Cancer: Medical Therapeutic Approaches

Stage: The Language of Cancer

Stocktake of Melanoma Research in New Zealand

Molecular Testing Updates. Karen Rasmussen, PhD, FACMG Clinical Molecular Genetics Spectrum Medical Group, Pathology Division Portland, Maine

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Corporate Medical Policy

OSCaR UPDATE. Manager s Update Donald Shipley, MS. Oregon State Cancer Registry

Update on the National HPB Audit. Richard M Charnley Iain C Cameron

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

Guide to Understanding Lung Cancer

Innovative RT SBRT. The variables with REQ in superscript are required.

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging

Measure Description. Denominator Statement

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Hepatobiliary and Pancreatic Malignancies

Provincial Sarcoma Services Plan VERSION 2.0 DECEMBER 2015

Targeted Therapies in the Management of Non-Small Cell Lung Cancer. A Multi-Disciplinary Approach

Traditional Approaches to Treating NSCLC, Part 2: Neoadjuvant Combined Modality, Locally Advanced, and Metastatic NSCLC

Congenital lung anomalies (CLA) with prenatal diagnosis multicentric database

Veterans and Bladder Cancer webinar. Part I: Medical Overview

NICE BULLETIN Diagnosis & treatment of prostate cancer

Liverpool Ocular Oncology Biobank

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

Requirements for Abstracted Text

SBRT in Pancreas Cancer Role of The Radiosurgery Society

The Cancer Research UK Stratified Medicine Programme: Phases One and Two Dr Emily Shaw

Decipher Bladder Predicts Which Patients May Benefit from Neoadjuvant Chemotherapy Prior to Radical Cystectomy

Population based studies in Pancreatic Diseases. Satish Munigala

WHO BENEFITS FROM ADJUVANT CHEMOTHERAPY RADIATION CHEMORADIATION? Dr. Paul Gardiner April 23, 2001 Discipline of Surgery Grand Rounds

Janus Serum Bank. Hilde Langseth MSc, PhD Senior Researcher and head of Janus Serum Bank Cancer Registry of Norway Department of Research

The Terry Fox Pan-Canadian Enhanced Pancreatic Cancer Profiling for Individualized Care (EPPIC) Project 19 Sep :00am-5:30pm

Evaluation of Cancer Outcomes Barwon South West Registry

Pathology Student Interest Group. Sponsored by the College of American Pathologists

ASKLEPIOS Course ADVANCED ONCOLOGIC IMAGING. Education in partnership. September 30 October 1, 2016 Kazan/Russia. myesr.org/esor

This page explains some of the medical words that you may hear when you are finding out about pancreatic cancer and how it is treated.

Transcription:

Base Anatomo Clinique de l Adénocarcinome Pancréatique Coordinator Dr BOURNET Barbara Project Manager Cindy Canivet Service de Gastroentérologie et Nutrition CHU de Toulouse

Aims of BACAP Incidence rate in France: 8 to 10/100 000 per year To build a clinical and biological database on the best quality standards, around a network of clinicians, surgeons, pathologists, epidemiologists. To make this database available to the scientific community to explore carcinogenesis, develop detection and diagnostic biomarkers and new therapeutic targets.

Partners BACAP is a multidisciplinary network 16 clinical centers for the patients recruitment with at least 3 clinical specialties. 2 epidemiological teams 6 scientific teams 1 data center

2 4 2 1 1 1 2 2 1

Regulatory BACAP is not a biomedical research project Necessity to obtain : CCTIRS ( Comité Consultatif sur le Traitement de l Information de Recherche dans le domaine de la Santé) authorization CNIL (Comission Nationale Informatique et Liberté) authorization Ethic comitee approval A collection declaration to the ministry of research and health Redaction of a consortium contract for the network

Governance Scientific Committee - Coordination - 1 representative for each body - External representatives (learned societies, cooperating group.) Coordination: - Coordinator: B Bournet - Project Manager : C Canivet Steering Committee - Coordination - Each investigation teams referee

Methodology This is a national monothematic, multicentric and prospective project Inclusion criteria: Patients with adenocarcinoma specifically located in the pancreas regardless the stage considered (resectable, locally advanced, unresectable or metastatic) and virgin of any chemotherapy treatment for the pancreas Exclusion criteria: Patients with previous chemotherapy treatment for the pancreas

Collected data From patient questionnaire: Demographic : Year of birth, gender, school level, job Risk factors linked to PDAC : Alcohol and tobacco consumption, MTEV risks, family cancer Clinic : Weight evolution, height, WHO performance status, medical comorbidities, past history of other cancer, date of first symptoms/description, diagnostic data, tumor information From medical exam: Imagery : TDM, Echo-endoscopy, MRI, PET-SCAN, for each exam details about tumor localization, expansion, ganglia, metastasis are collected (at the diagnosis and follow-up) Biologic : full biologic analysis, CA19.9 Therapeutic : medical, surgical, radiotherapeutic, palliative strategies with evaluation of response and tolerance of the treatment Survival data Date of death

Biobank Tumor/Pathology :Pre-therapeutic biopsies, tumor banking, ptnm stage, Histology, DNA and RNA from tumor cells. Biological samples : whole blood, serum, plasma and saliva Blood samples are collected at the diagnostic before any treatment. All patients included in BACAP have a blood sample

Biological collection Biological sample Origin of the sample Quantity of the sample/ concentration available Number of aliquot Preservation or storage conditions At Baseline (date of the first sampling): 15th May2014 Tissues biopsies Pancreatic tissue or metastasis [1-4] Paraffin or liquid nitrogen Plasma Blood 500µl [4-6] -80 C Serum Blood 500µl [4-6] -80 C Total whole Blood Blood 1ml [4-6] -80 C saliva Saliva 1ml 1-80 C DNA Pancreas [40-2000ng] 1-2 -80 C RNA Pancreas [40-2000ng] 1-2 -80 C

Biological collection Biological sample Origin of the sample Quantity of the sample/ concentration available Number of aliquot Preservation or storage conditions At Baseline (date of the first sampling): 15th May2014 Tissues biopsies Pancreatic tissue or metastasis [1-4] Paraffin or liquid nitrogen Plasma Blood 8500 500µl samples [4-6] -80 C Serum Blood 500µl [4-6] -80 C Total whole Blood Blood 1ml [4-6] -80 C saliva Saliva 1ml 1-80 C DNA Pancreas [40-2000ng] 1-2 -80 C RNA Pancreas [40-2000ng] 1-2 -80 C

Recruitment Number of patients 450 400 350 300 250 200 150 424 patients 100 50 0

Biological samples and data modalities access To access biological samples and/or data, the research team need to fill out a specific research project proposal, available on the BACAP website: http://www.chu-toulouse.fr/-projet- bacap- Biological samples and clinical data are transferred after the scientific and steering committee decision. A partnership contract is signed with each scientific team using samples and/or data of BACAP.

Thank You for your attention!